Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis

Author(s): Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, et al.

Abstract

Objectives: To determine the importance of margin status and other prognostic factors associated with the recurrence and survival of patients with squamous cell vulvar carcinoma.

Methods: Data were analyzed using Kaplan-Meier methods and Cox proportional hazards regression. All slides were re-reviewed by two gynecologic pathologists.

Results: Ninety patients (median age: 69) were treated for vulvar carcinoma from 1984 to 2002, including 28 FIGO stage I, 20 stage II, 26 stage III and 16 with stage IV disease. Sixty-three (70%) patients underwent complete radical vulvectomies and 27 (30%) had modified radical vulvectomies. Nineteen (20%) patients received adjuvant radiotherapy. Five-year disease-specific survival rates were 100%, 100%, 86% and 29% for stages I-IV, respectively. None of the 30 patients with a pathologic margin distance >8 mm had local recurrence. Of the 53 women with tumor-free pathologic margin of <8 mm, 12 (23%) had a local recurrence. Moreover, women with >2 positive groin nodes had significantly higher recurrence risk compared to those with <2 metastatic groin nodes (p<0.001). On multivariate analysis, positive groin nodes and margin distance were important prognostic factors for recurrence. Moreover, stage, tumor size, margin distance, and depth of invasion were significant independent predictors for disease-specific survival. The median follow-up was 58 months (range: 2-188).

Conclusions: Pathologic margin distance is an important predictor of local vulvar recurrence. Our data suggest that a > or =8-mm pathologic margin clearance leads to a high rate of loco-regional control.

Similar Articles

Trends in the incidence of invasive and in situ vulvar carcinoma

Author(s): Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA

New aspects of vulvar cancer: changes in localization and age of onset

Author(s): Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG

The impact of improving outcomes guidance on surgical management of vulval squamous cell cancer in southwest England (1997-2002)

Author(s): Falconer AD, Hirschowitz L, Weeks J, Murdoch J; South West Gynaecology Tumour Panel

Groin dissection practices among gynecologic oncologists treating early vulvar cancer

Author(s): Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JK, et al.

A proposed glossary of terminology related to the surgical treatment of vulvar carcinoma

Author(s): Micheletti L, Preti M, Zola P, Zanotto Valentino MC, Bocci C, et al.

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers

Author(s): Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S

Carcinoma of the vulva

Author(s): Rutledge F, Smith JP, Franklin EW

Squamous carcinoma of the vulva: results of treatment, 1938 to 1976

Author(s): Benedet JL, Turko M, Fairey RN, Boyes DA

Changing trends in the surgical treatment of invasive carcinoma of the vulva

Author(s): Cavanagh D, Roberts WS, Bryson SC, Marsden DE, Ingram JM, et al.

Management of regional lymph nodes and their prognostic influence in vulvar cancer

Author(s): Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG

Squamous vulvar cancer: a clinically based individualization of treatment

Author(s): Rodolakis A, Diakomanolis E, Voulgaris Z, Akrivos T, Vlachos G, et al.

Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva

Author(s): Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, et al.

Carcinoma of the vulva

Author(s): Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY

Changes in the management of vulval cancer

Author(s): Dhar KK, Woolas RP

Individualization of treatment for stage I squamous cell vulvar carcinoma

Author(s): Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS